Cargando…
Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology
The tumor micro-environment (TME) plays an important role in various cancers, including gliomas. We estimated immune cell type-specific gene expression profiles in 3 large clinically annotated glioma datasets using CIBERSORTx and LM22/LM10 blood-based immune signatures and found that the proportions...
Autores principales: | Mehani, Bharati, Asanigari, Saleembhasha, Chung, Hye-Jung, Dazelle, Karen, Singh, Arashdeep, Hannenhalli, Sridhar, Aldape, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830123/ https://www.ncbi.nlm.nih.gov/pubmed/35144680 http://dx.doi.org/10.1186/s40478-022-01323-w |
Ejemplares similares
-
Long non-coding RNAs as pan-cancer master gene regulators of associated protein-coding genes: a systems biology approach
por: Saleembhasha, Asanigari, et al.
Publicado: (2019) -
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019) -
Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020) -
IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019) -
Metabolic Reprogramming in Mutant IDH1 Glioma Cells
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2015)